We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.08B
AUM Growth
+$429M
Cap. Flow
+$303M
Cap. Flow %
9.83%
Top 10 Hldgs %
12.86%
Holding
1,336
New
161
Increased
732
Reduced
335
Closed
102

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$47.7M
2
V icon
Visa
V
+$21.2M
3
CVX icon
Chevron
CVX
+$16.5M
4
PEP icon
PepsiCo
PEP
+$12.2M
5
ABT icon
Abbott
ABT
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 24.11%
2 Healthcare 14.19%
3 Consumer Discretionary 11.25%
4 Industrials 10.72%
5 Financials 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEEV icon
751
Veeva Systems
VEEV
$38.4B
$540K 0.02%
2,936
+837
+40% +$143K
LTC
752
LTC Properties
LTC
$2.05B
$538K 0.02%
15,303
+2,381
+18% +$85.7K
DCFC
753
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$535K 0.02%
2,090
+1,090
+109% +$319K
NOK icon
754
Nokia
NOK
$52.7B
$531K 0.02%
108,230
-522
-0.5% -$2.46K
NWSA icon
755
News Corp Class A
NWSA
$15.5B
$530K 0.02%
30,704
-38,984
-56% -$712K
EL icon
756
Estee Lauder
EL
$31.8B
$530K 0.02%
2,149
+576
+37% +$146K
NNN icon
757
NNN REIT
NNN
$8.71B
$529K 0.02%
11,978
+2,070
+21% +$94.2K
WIT icon
758
Wipro
WIT
$19.5B
$527K 0.02%
234,962
+106,672
+83% +$254K
HZNP
759
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$527K 0.02%
4,833
-98,257
-95% -$10.9M
BCH icon
760
Banco de Chile
BCH
$20.7B
$527K 0.02%
26,984
+6,629
+33% +$138K
WDS icon
761
Woodside Energy
WDS
$44.3B
$526K 0.02%
23,451
+6,115
+35% +$147K
IDXX icon
762
Idexx Laboratories
IDXX
$46.2B
$525K 0.02%
1,050
+249
+31% +$119K
IMTX icon
763
Immatics
IMTX
$1.33B
$523K 0.02%
75,841
-2,615
-3% -$21.4K
IGMS
764
DELISTED
IGM Biosciences
IGMS
$523K 0.02%
38,078
-1,405
-4% -$29.1K
PVH icon
765
PVH
PVH
$3.91B
$523K 0.02%
5,866
+309
+6% +$25.2K
LYEL icon
766
Lyell Immunopharma
LYEL
$365M
$522K 0.02%
11,056
-79
-0.7% -$4.22K
BAM icon
767
Brookfield Asset Management
BAM
$88.4B
$520K 0.02%
+15,894
New +$516K
RCI icon
768
Rogers Communications
RCI
$19.1B
$519K 0.02%
11,213
+229
+2% +$10.9K
TDOC icon
769
Teladoc Health
TDOC
$1.24B
$518K 0.02%
19,994
+7,313
+58% +$196K
BCYC
770
Bicycle Therapeutics
BCYC
$288M
$517K 0.02%
24,287
+330
+1% +$8.28K
PCH
771
DELISTED
PotlatchDeltic
PCH
$516K 0.02%
10,424
-49,651
-83% -$2.33M
CSIQ icon
772
Canadian Solar
CSIQ
$1.08B
$514K 0.02%
12,905
-1,613
-11% -$64K
FICO icon
773
Fair Isaac
FICO
$22.4B
$514K 0.02%
731
-4,825
-87% -$3.21M
PLUG icon
774
Plug Power
PLUG
$3.1B
$513K 0.02%
43,796
-12,982
-23% -$186K
CAE icon
775
CAE Inc. Common Shares
CAE
$8.74B
$511K 0.02%
+22,617
New +$494K

Similar funds

Vident Investment Advisory's Q1 2023 Portfolio in Review

As of Q1 2023, Vident Investment Advisory held 1,336 positions worth $3.08B, up 16% from $2.65B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Vident Investment Advisory deployed $303M of net new capital in Q1 2023, opening 161 new positions and adding to 732 existing holdings. Its largest new stake was Hormel Foods: 165,491 shares worth $6.6M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Philip Morris, an estimated $17.1M trimmed.

  • Vident Investment Advisory's largest Q1 2023 buy was Hormel Foods: 165,491 shares worth $6.6M.
  • Vident Investment Advisory added most to Apple in Q1 2023, an estimated $47.7M increase.
  • Vident Investment Advisory's biggest Q1 2023 reduction was Philip Morris, cutting an estimated $17.1M.
  • Vident Investment Advisory fully exited Coherent in Q1 2023, selling an estimated $5.89M.
  • Vident Investment Advisory's ten largest holdings make up 13% of its $3.08B portfolio in Q1 2023.
  • Vident Investment Advisory opened 161 new positions and closed 102 in Q1 2023.
  • Vident Investment Advisory's portfolio value rose 16% quarter-over-quarter to $3.08B.

Based on Vident Investment Advisory's 13F filing for Q1 2023, filed 15 May 2023.